September 2020 Quick Hits
September is over — it’s time for October! Here’s a recap of all the top news from the CBD industry from the past month or so, right here on Direct CBD Online. At the top of the list, of course, is the Queen of CBD, Martha Stewart.
Martha Stewart, Blissed Out on CBD, Is Doing Just Fine
In case you missed this write-up in the New York Times, here you go. “Just fine,” is being modest. Martha Stewart — and, of course, Martha Stewart CBD — are perhaps the most fabulous thing to happen to this year. Martha Stewart decided to enter the CBD space and partner with Canopy Growth, a world-renowned cannabis brand with the desire of normalizing the remedy.
Martha has become a personal advocate of CBD wellness. She desires to bring her flair for flavor, presentation, quality, and trustworthiness to homes everywhere. You can gain some behind-the-scenes insight about her product development, particularly those enticing gummies, from our very own podcast.
Listen or read along here, Inside the Martha Stewart CBD Launch With Guest Steven Leung of Canopy Growth >>
Cannabidiol (CBD) Market Expected to Reach USD 938.9 Million by 2027
The surge of the global CBD market is due to a variety of factors, and it is currently projected to grow by about 30% each year. Currently, North America holds the majority of the stake in the market, followed by Europe. Another key element of the CBD market is the prevalence of online retailers, like Direct CBD Online. It’s the new norm for many industries that retail space has become less practical or simply not needed due to cost as well as pandemic-related restrictions. As discussed in the following article, the pandemic may also motivate more individuals to try CBD as a way of improving overall wellness or relieving anxiety.
First-ever Cannabinoid Anxiety Relief Education Study (C.A.R.E.S.) Will Explore CBD and Cannabis Efficacy for Anxiety Aggravated by COVID-19
Brought to you by the University of California, Irvine Departments of Emergency Medicine and Informatics, C.A.R.E.S. is an exploratory survey reaching millions of CBD and cannabis users across the US. The study will assess the potential role of cannabinoids in reducing anxiety and insomnia and improving quality of life, especially through the scope of COVID-19 impacts. This data will likely prove crucial to monitor the potential impacts of CBD use among returning or new users. Data like this can also provide further insight into legal or medical parameters to come.
Looking for other recent CBD news?
If you think you may have missed something from previous months, don’t worry, we’ve got a few collections of relevant articles for you right here.
Looking for more great video content? Be sure to check out our YouTube Channel. It’s full of product reviews, FAQs, and more! As always, we’re glad to serve as your trusted source of CBD news. Check back next month for more!
Leave a Reply